We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$143M
2
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$49M
3
CCVI
Churchill Capital Corp VI
CCVI
+$34.2M
4
AMD icon
Advanced Micro Devices
AMD
+$27.5M
5
CLDX icon
Celldex Therapeutics
CLDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LW icon
126
Lamb Weston
LW
$7.17B
$767K 0.07%
12,802
-1,643
-11% -$102K
C icon
127
PUT
Citigroup
C
$228B
$760K 0.07%
65,100
-3,200
-5% -$198K
IDXX icon
128
Idexx Laboratories
IDXX
$47.1B
$746K 0.07%
1,363
-475
-26% -$250K
ISRG icon
129
Intuitive Surgical
ISRG
$141B
$739K 0.07%
2,451
+797
+48% +$233K
VNE
130
DELISTED
Veoneer, Inc.
VNE
$739K 0.07%
+20,000
New +$712K
INVZW
131
DELISTED
Innoviz Technologies Warrant
INVZW
$736K 0.07%
721,715
-721,715
-50% -$877K
BMRN icon
132
BioMarin Pharmaceuticals
BMRN
$13.3B
$718K 0.07%
9,312
+3,196
+52% +$267K
TBLAW
133
DELISTED
Taboola.com Ltd Warrant
TBLAW
$698K 0.07%
697,500
– –
KVSA
134
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$665K 0.06%
68,000
– –
IQV icon
135
IQVIA
IQV
$40B
$645K 0.06%
2,790
+912
+49% +$216K
BAX icon
136
Baxter International
BAX
$14.3B
$634K 0.06%
8,171
+2,652
+48% +$222K
AGIO icon
137
Agios Pharmaceuticals
AGIO
$1.93B
$604K 0.06%
+20,750
New +$634K
RF icon
138
Regions Financial
RF
$26.8B
$592K 0.06%
26,612
-1,348
-5% -$31.7K
XLE icon
139
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$580K 0.06%
137,200
-62,800
-31% -$2.18M
IMPX.WS
140
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$580K 0.06%
733,039
+436,963
+148% +$355K
VYGG.WS
141
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$573K 0.06%
+796,318
New +$590K
KRE icon
142
State Street SPDR S&P Regional Banking ETF
KRE
$4.58B
$572K 0.06%
+8,300
New +$605K
DNAB
143
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$568K 0.05%
58,220
-199,780
-77% -$1.94M
SRPT icon
144
Sarepta Therapeutics
SRPT
$1.89B
$564K 0.05%
7,218
+6,356
+737% +$487K
MTD icon
145
Mettler-Toledo International
MTD
$28.8B
$562K 0.05%
409
+132
+48% +$191K
MSOS icon
146
AdvisorShares Pure US Cannabis ETF
MSOS
$898M
$560K 0.05%
26,824
-115,297
-81% -$2.52M
HTZ icon
147
Hertz
HTZ
$905M
$554K 0.05%
25,006
-193,228
-89% -$4.06M
MJ icon
148
Amplify Alternative Harvest ETF
MJ
$108M
$554K 0.05%
+4,454
New +$535K
FVT
149
DELISTED
Fortress Value Acquisition Corp. III
FVT
$554K 0.05%
56,220
– –
BEEM icon
150
Beam Global
BEEM
$26M
$552K 0.05%
27,000
-73,000
-73% -$1.06M
4 5
6
7 8

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.